Watertown, MA, United States of America

Robert G Hesse

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Iviva Medical, Inc.. Active years: 2022-2025.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert G. Hesse

Introduction

Robert G. Hesse is a notable inventor based in Watertown, MA, who has made significant contributions to the field of biological fluid purification. With a total of three patents to his name, Hesse's work focuses on enhancing the functionality of endocrine glands through innovative apparatus and methods.

Latest Patents

Hesse's latest patents include an "Apparatus for Supplementing Function of Endocrine Glands," which discloses methods for blood and other biological fluid purification using a membrane with cell-containing vascular channel systems and filtration channel systems. Additionally, he has developed a patent titled "Biological Fluid Purification with Biocompatible Membranes," which also outlines similar methods for purification and membrane fabrication.

Career Highlights

Hesse is currently associated with Iviva Medical, Inc., where he continues to advance his research and development efforts. His work is pivotal in the medical field, particularly in improving the quality of biological fluid purification processes.

Collaborations

Throughout his career, Hesse has collaborated with esteemed colleagues such as Harald C. Ott and Maria Jaramillo. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the development of new technologies.

Conclusion

Robert G. Hesse's contributions to the field of biological fluid purification through his patents and collaborations highlight his role as a

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…